Document is current
Any future updates will be listed below
-
Authors
Nagai, Shin
Hiraiwa, Hiroaki https://orcid.org/0000-0002-1606-7037
Ito, Ryota
Koyama, Yuichiro
Kondo, Kiyota
Kazama, Shingo
Kondo, Toru https://orcid.org/0000-0001-6853-7574
Morimoto, Ryota https://orcid.org/0000-0003-0931-3188
Okumura, Takahiro https://orcid.org/0000-0001-5076-2052
Ito, Hideki https://orcid.org/0000-0002-0164-6108
Yoshizumi, Tomo https://orcid.org/0000-0002-3854-5108
Mutsuga, Masato https://orcid.org/0000-0001-9740-2142
Murohara, Toyoaki https://orcid.org/0000-0003-2723-6243
- License Information
-
More Information
Article History
Received: 28 December 2023
Accepted: 12 May 2024
First Online: 6 June 2024
Declarations
:
: H.H. received research grants from Konica Minolta Inc., Konica Minolta Science and Technology Foundation, and Kowa Life Science Foundation. T.K. received lecture fees from AstraZeneca K.K., Nippon Boehringer Ingelheim Co. Ltd., Ono Pharmaceutical Co. Ltd., Kowa Co. Ltd., and Novartis Pharma K.K. T.O. received lecture fees from Ono Pharmaceutical Co. Ltd., Novartis Pharma K.K., Otsuka Pharma Ltd., Nippon Boehringer Ingelheim Co. Ltd., AstraZeneca K.K, and Pfizer Japan Inc., and research grants from Ono Pharmaceutical Co. Ltd., Pfizer Japan Inc., Alnylam Pharmaceuticals Inc., and Alexion Pharmaceuticals Inc. T.M. received an unrestricted research grant from the Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas Pharma Inc., Daiichi-Sankyo Co. Ltd., Sumitomo Pharma Co. Ltd., Kowa Co. Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corp., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K.K., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd. The authors declare that they have no conflicts of interest associated with this manuscript.
: The patient and his family provided written informed consent, which was approved by our institution’s ethics committee on human research.
